DBV Technologies (DBVT) Change in Account Payables (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Change in Account Payables of $100000.0 for Q2 2026, down 97.5% year-on-year from $4.0 million in Q2 2025, and up 120.0% on a QoQ basis from -$500000.0 in Q1 2026.

DBV Technologies (DBVT) Change in Account Payables (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Change in Account Payables for 7 consecutive years, with $100000.0 the latest figure, recorded in Q2 2026.

  • Quarterly Change in Account Payables fell 97.5% year-over-year to $100000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $483000.0 (down 97.35% YoY) and the FY2025 annual result came in at $15.8 million, up 5702.57% from the prior year.
  • Change in Account Payables climbed to $100000.0 in Q2 2026 per DBVT's latest filing, from -$500000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for DBVT reached as high as $10.9 million in Q1 2025 and fell as low as -$4.8 million in Q1 2024.
  • A 5-year average of $1.5 million and a median of $731000.0 in 2024 frame the typical range for Change in Account Payables.
  • The largest YoY upside for Change in Account Payables was 23668.42% in 2023 against a maximum downside of 786.15% in 2023.
  • Year by year, Change in Account Payables stood at -$2.2 million in 2022, then soared by 400.0% to $6.7 million in 2023, then slumped by 79.76% to $1.4 million in 2024, then rose by 10.13% to $1.5 million in 2025, then sank by 93.33% to $100000.0 in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $100000.0, -$500000.0, and $1.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - 100,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 100,000.00
Jun 30, 2026 100,000.00
Mar 31, 2026 -500,000.00
Mar 31, 2026 -500,000.00
Dec 31, 2025 1.50 Mn
Dec 31, 2025 1.50 Mn
Sep 30, 2025 -617,000.00
Sep 30, 2025 -617,000.00
Jun 30, 2025 4.00 Mn
Jun 30, 2025 4.00 Mn
Mar 31, 2025 10.90 Mn
Mar 31, 2025 10.90 Mn
Dec 31, 2024 1.36 Mn
Dec 31, 2024 1.36 Mn
Sep 30, 2024 1.96 Mn
Sep 30, 2024 1.96 Mn
Jun 30, 2024 1.76 Mn
Jun 30, 2024 1.76 Mn
Mar 31, 2024 -4.81 Mn
Mar 31, 2024 -4.81 Mn